Transient glyco-engineering to produce recombinant IgA1 with defined N-and O-glycans in plants

Frontiers in Plant Science

Volumn 7, Issue JAN2016, 2016, Pages

  Dicker, Martina ^a   Tschofen, Marc ^a   Maresch, Daniel ^a   König, Julia ^a   Juarez, Paloma ^b   Orzaez, Diego ^b   Altmann, Friedrich ^a   Steinkellner, Herta ^a   Strasser, Richard ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b Universitat Politècnica de València   (Spain)

Author keywords

Antibody; Glyco engineering; Monomeric IgA; N glycosylation; O glycosylation; Plant made pharmaceuticals; Protein glycosylation; Recombinant glycoprotein

Indexed keywords

EID: 84956708764     PISSN: None     EISSN: 1664462X     Source Type: Journal    
DOI: 10.3389/fpls.2016.00018     Document Type: Article

References (57)

1. Ahmed, A. A., Giddens, J., Pincetic, A., Lomino, J. V., Ravetch, J. V., Wang, L. X., et al. (2014). Structural characterization of anti-inflammatory immunoglobulin G Fc proteins. J. Mol. Biol. 426, 3166-3179. doi: 10.1016/j.jmb.2014.07.006
2. Atkin, J. D., Pleass, R. J., Owens, R. J., and Woof, J. M. (1996). Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly. J. Immunol. 157, 156-159.
3. Bakema, J. E., and van Egmond, M. (2011). Immunoglobulin A: a next generation of therapeutic antibodies? MAbs 3, 352-361. doi: 10.4161/mabs.3.4.16092
4. Basu, D., Liang, Y., Liu, X., Himmeldirk, K., Faik, A., Kieliszewski, M., et al. (2013). Functional identification of a hydroxyproline-O-galactosyltransferase specific for arabinogalactan protein biosynthesis in Arabidopsis. J. Biol. Chem. 288, 10132-10143. doi: 10.1074/jbc.M112.432609
5. Beck, A., and Reichert, J. M. (2012). Marketing approval of mogamulizumab: a triumph for glyco-engineering. MAbs 4, 419-425. doi: 10.4161/mabs.20996
6. Bennett, E. P., Mandel, U., Clausen, H., Gerken, T. A., Fritz, T. A., and Tabak, L. A. (2012). Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology 22, 736-756. doi: 10.1093/glycob/cwr182
7. Boross, P., Lohse, S., Nederend, M., Jansen, J. H., Van Tetering, G., Dechant, M., et al. (2013). IgA EGFR antibodies mediate tumour killing in vivo. EMBO Mol. Med. 5, 1213-1226. doi: 10.1002/emmm.201201929
8. Castilho, A., Bohorova, N., Grass, J., Bohorov, O., Zeitlin, L., Whaley, K., et al. (2011). Rapid high yield production of different glycoforms of Ebola virus monoclonal antibody. PLoS ONE 6:e26040. doi: 10.1371/journal.pone.0026040
9. Castilho, A., Gruber, C., Thader, A., Oostenbrink, C., Pechlaner, M., Steinkellner, H., et al. (2015). Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation. MAbs 7, 863-870. doi: 10.1080/19420862.2015.1053683
10. Castilho, A., Neumann, L., Daskalova, S., Mason, H. S., Steinkellner, H., Altmann, F., et al. (2012). Engineering of sialylated mucin-type O-glycosylation in plants. J. Biol. Chem. 287, 36518-36526. doi: 10.1074/jbc.M112.402685
11. Castilho, A., Pabst, M., Leonard, R., Veit, C., Altmann, F., Mach, L., et al. (2008). Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis. Plant Physiol. 147, 331-339. doi: 10.1104/pp108.117572
12. Castilho, A., Strasser, R., Stadlmann, J., Grass, J., Jez, J., Gattinger, P., et al. (2010). In planta protein sialylation through overexpression of the respective mammalian pathway. J. Biol. Chem. 285, 15923-15930. doi: 10.1074/jbc.M109.088401
13. Castilho, A., Windwarder, M., Gattinger, P., Mach, L., Strasser, R., Altmann, F., et al. (2014). Proteolytic and N-glycan processing of human α1-antitrypsin expressed in Nicotiana benthamiana. Plant Physiol. 166, 1839-1851. doi: 10.1104/pp114.250720
14. Deshpande, N., Jensen, P. H., Packer, N. H., and Kolarich, D. (2010). GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA. J. Proteome Res. 9 1063-1075. doi: 10.1021/pr900956x
15. Fernandez-del-Carmen, A., Juárez, P., Presa, S., Granell, A., and Orzáez, D. (2013). Recombinant jacalin-like plant lectins are produced at high levels in Nicotiana benthamiana and retain agglutination activity and sugar specificity. J. Biotechnol. 163, 391-400. doi: 10.1016/j.jbiotec.2012.11.017
16. Ferrara, C., Grau, S., Jäger, C., Sondermann, P., Brünker, P., Waldhauer, I., et al. (2011). Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc. Natl. Acad. Sci. U.S.A. 108, 12669-12674. doi: 10.1073/pnas.1108455108
17. Forthal, D. N., Gach, J. S., Landucci, G., Jez, J., Strasser, R., Kunert, R., et al. (2010). Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J. Immunol. 185, 6876-6882. doi: 10.4049/jimmunol.1002600
18. Goede, V., Klein, C., and Stilgenbauer, S. (2015). Obinutuzumab (GA101) for the treatment of chronic lymphocytic leukemia and other B-cell non-hodgkin’s lymphomas: a glycoengineered type II CD20 antibody. Oncol. Res. Treat. 38, 185-192. doi: 10.1159/000381524
19. Huang, J., Guerrero, A., Parker, E., Strum, J. S., Smilowitz, J. T., German, J. B., et al. (2015). Site-specific glycosylation of secretory immunoglobulin A from human colostrum. J. Proteome Res. 14, 1335-1349. doi: 10.1021/pr500826q
20. Iwasaki, H., Zhang, Y., Tachibana, K., Gotoh, M., Kikuchi, N., Kwon, Y. D., et al. (2003). Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2. J. Biol. Chem. 278, 5613-5621. doi: 10.1074/jbc.M211097200
21. Jefferis, R. (2009). Glycosylation as a strategy to improve antibody-based therapeutics. Nat. Rev. Drug Discov. 8, 226-234. doi: 10.1038/nrd2804
22. Juarez, P., Huet-Trujillo, E., Sarrion-Perdigones, A., Falconi, E. E., Granell, A., and Orzaez, D. (2013). Combinatorial analysis of secretory immunoglobulin A (sIgA) expression in plants. Int. J. Mol. Sci. 14, 6205-6222. doi: 10.3390/ijms14036205
23. Juárez, P., Presa, S., Espí, J., Pineda, B., Antón, M. T., Moreno, V., et al. (2012). Neutralizing antibodies against rotavirus produced in transgenically labelled purple tomatoes. Plant Biotechnol. J. 10, 341-352. doi: 10.1111/j.1467-7652.2011.00666.x
24. Karnoup, A. S., Turkelson, V., and Anderson, W. H. (2005). O-linked glycosylation in maize-expressed human IgA1. Glycobiology 15, 965-981. doi: 10.1093/glycob/cwi077
25. Kong, Y., Joshi, H. J., Schjoldager, K. T., Madsen, T. D., Gerken, T. A., Vester- Christensen, M. B., et al. (2015). Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis. Glycobiology 25, 55-65. doi: 10.1093/glycob/cwu089
26. Lifely, M. R., Hale, C., Boyce, S., Keen, M. J., and Phillips, J. (1995). Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. Glycobiology 5, 813-822. doi: 10.1093/glycob/5.8.813
27. Lin, C. W., Tsai, M. H., Li, S. T., Tsai, T. I., Chu, K. C., Liu, Y. C. et al. (2015). A common glycan structure on immunoglobulin G for enhancement of effector functions. Proc. Natl. Acad. Sci. USA. 112, 10611-10616. doi: 10.1073/pnas.1513456112
28. Loos, A., Gruber, C., Altmann, F., Mehofer, U., Hensel, F., Grandits, M., et al. (2014). Expression and glycoengineering of functionally active heteromultimeric IgM in plants. Proc. Natl. Acad. Sci. USA. 111, 6263-6268. doi: 10.1073/pnas.1320544111
29. Ma, J. K., Drossard, J., Lewis, D., Altmann, F., Boyle, J., Christou, P., et al. (2015). Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnol. J. 13, 1106-1120. doi: 10.1111/pbi.12416
30. Ma, J. K., Hiatt, A., Hein, M., Vine, N. D., Wang, F., Stabila, P., et al. (1995). Generation and assembly of secretory antibodies in plants. Science 268, 716-719. doi: 10.1126/science.7732380
31. Mucha, J., Svoboda, B., Kappel, S., Strasser, R., Bencur, P., Fröhwein, U., et al. (2002). Two closely related forms of UDP-GlcNAc: alpha6-Dmannoside beta1,2-N-acetylglucosaminyltransferase II occur in the clawed frog Xenopus laevis. Glycoconj. J. 19, 187-195. doi: 10.1023/A:1024201824354
32. Novak, J., Julian, B. A., Mestecky, J., and Renfrow, M. B. (2012). Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin. Immunopathol. 34, 365-382. doi: 10.1007/s00281-012-0306-z
33. Parsons, J., Altmann, F., Graf, M., Stadlmann, J., Reski, R., and Decker, E. L. (2013). A gene responsible for prolyl-hydroxylation of moss-produced recombinant human erythropoietin. Sci. Rep. 3, 3019. doi: 10.1038/srep03019
34. Paul, M., Reljic, R., Klein, K., Drake, P. M., Van Dolleweerd, C., Pabst, M., et al. (2014). Characterization of a plant-produced recombinant human secretory IgA with broad neutralizing activity against HIV. MAbs 6, 1585-1597. doi: 10.4161/mabs.36336
35. Pinkhasov, J., Alvarez, M. L., Rigano, M. M., Piensook, K., Larios, D., Pabst, M., et al. (2011). Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice. Plant Biotechnol. J. 9, 991-1001. doi: 10.1111/j.1467-7652.2011.00614.x
36. Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J. B., et al. (2014). Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47-53. doi: 10.1038/nature13777
37. Ratner, M. (2014). Genentech’s glyco-engineered antibody to succeed Rituxan. Nat. Biotechnol. 32, 6-7. doi: 10.1038/nbt0114-6b
38. Reinhart, D., and Kunert, R. (2015). Upstream and downstream processing of recombinant IgA. Biotechnol. Lett. 37, 241-251. doi: 10.1007/s10529-014-1686-z
39. Reusch, D., and Tejada, M. L. (2015). Fc glycans of therapeutic antibodies as critical quality attributes (CQAs). Glycobiology 25, 1325-1334. doi: 10.1093/glycob/cwv065
40. Royle, L., Roos, A., Harvey, D. J., Wormald, M. R., Van Gijlswijk-Janssen, D., Redwan, E.-R., et al. (2003). Secretory IgA N-and O-glycans provide a link between the innate and adaptive immune systems. J. Biol. Chem. 278, 20140-20153. doi: 10.1074/jbc.M301436200
41. Saito, F., Suyama, A., Oka, T., Yoko O T., Matsuoka K., Jigami Y., et al. (2014). Identification of novel peptidyl serine α-galactosyltransferase gene family in plants. J. Biol. Chem. 289, 20405-20420. doi: 10.1074/jbc.M114.553933
42. Seifert, G. J., and Roberts, K. (2007). The biology of arabinogalactan proteins. Annu. Rev. Plant Biol. 58, 137-161. doi: 10.1146/annurev.arplant.58.032806.103801
43. Sørensen, V., Rasmussen, I. B., Sundvold, V., Michaelsen, T. E., and Sandlie, I. (2000). Structural requirements for incorporation of J chain into human IgM and IgA. Int. Immunol. 12, 19-27. doi: 10.1093/intimm/12.1.19
44. Steentoft, C., Bennett, E. P., and Clausen, H. (2013). Glycoengineering of human cell lines using zinc finger nuclease gene targeting: SimpleCells with homogeneous GalNAc O-glycosylation allow isolation of the O-glycoproteome by one-step lectin affinity chromatography. Methods Mol. Biol. 1022, 387-402. doi: 10.1007/978-1-62703-465-4_29
45. Strasser, R. (2013). Engineering of human-type O-glycosylation in Nicotiana benthamiana plants. Bioengineered 4, 191-196. doi: 10.4161/bioe.22857
46. Strasser, R., Altmann, F., and Steinkellner, H. (2014). Controlled glycosylation of plant-produced recombinant proteins. Curr. Opin. Biotechnol. 30C, 95-100. doi: 10.1016/j.copbio.2014.06.008
47. Strasser, R., Bondili, J., Schoberer, J., Svoboda, B., Liebminger, E., Glössl, J., et al. (2007). Enzymatic properties and subcellular localization of Arabidopsis beta-N-acetylhexosaminidases. Plant Physiol. 145, 5-16. doi: 10.1104/pp.107.101162
48. Strasser, R., Castilho, A., Stadlmann, J., Kunert, R., Quendler, H., Gattinger, P., et al. (2009). Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J. Biol. Chem. 284, 20479-20485. doi: 10.1074/jbc.M109.014126
49. Strasser, R., Stadlmann, J., Schähs, M., Stiegler, G., Quendler, H., Mach, L., et al. (2008). Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J. 6, 392-402. doi: 10.1111/j.1467-7652.2008.00330.x
50. Strasser, R., Stadlmann, J., Svoboda, B., Altmann, F., Glössl, J., and Mach, L. (2005). Molecular basis of N-acetylglucosaminyltransferase I deficiency in Arabidopsis thaliana plants lacking complex N-glycans. Biochem. J. 387, 385-391. doi: 10.1042/BJ20041686
51. Subedi, G. P., and Barb, A. W. (2015). The structural role of antibody N-glycosylation in receptor interactions. Structure 23, 1573-1583. doi: 10.1016/j.str.2015.06.015
52. Suzuki, Y., Suzuki, H., Yasutake, J., and Tomino, Y. (2015). Paradigm shift in activity assessment of IgA nephropathy-optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting. Expert Opin. Biol. Ther. 15, 583-593. doi: 10.1517/14712598.2015.1006624
53. Taylor, C. M., Karunaratne, C. V., and Xie, N. (2012). Glycosides of hydroxyproline: some recent, unusual discoveries. Glycobiology 22, 757-767. doi: 10.1093/glycob/cwr188
54. Umaña, P., Jean-Mairet, J., Moudry, R., Amstutz, H., and Bailey, J. E. (1999). Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody dependent cellular cytotoxic activity. Nat. Biotechnol. 17, 176-180. doi: 10.1038/6179
55. Westerhof, L. B., Wilbers, R. H., Van Raaij, D. R., Nguyen, D. L., Goverse, A., Henquet, M. G., et al. (2014). Monomeric IgA can be produced in planta as efficient as IgG, yet receives different N-glycans. Plant Biotechnol. J. 12, 1333-1342. doi: 10.1111/pbi.12251
56. Yang, Z., Drew, D. P., Jørgensen, B., Mandel, U., Bach, S. S., Ulvskov, P., et al. (2012). Engineering mammalian mucin-type O-glycosylation in plants. J. Biol. Chem. 287, 11911-11923. doi: 10.1074/jbc.M111.312918
57. Yoo, E. M., Yu, L. J., Wims, L. A., Goldberg, D., and Morrison, S. L. (2010). Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines. MAbs 2, 320-334. doi: 10.4161/mabs.2.3.11802